# Evaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With Influenza

> **NCT03410862** · PHASE4 · COMPLETED · sponsor: **michael macknin** · enrollment: 87 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **DRUG:** Elderberry Extract
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03410862
- **Lead sponsor:** michael macknin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-29
- **Primary completion:** 2019-06-25
- **Final completion:** 2019-06-25
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2021-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03410862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03410862, "Evaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With Influenza". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03410862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*